The private price signal
I have about two minutes to dash this off, so forgive me for brevity. Something in Aaron’s latest post struck me. He quotes Frum: [Medicare’s pricing]
I have about two minutes to dash this off, so forgive me for brevity. Something in Aaron’s latest post struck me. He quotes Frum: [Medicare’s pricing]
David Frum thinks so: Unfortunately Brill’s piece is also inspiring more comment that the only solution is to extend Medicare to all: single-payer. Yet Brill
Joel Weissman and Michael Zinner summarize recent work on robotic surgery. Wright et al compared the use of robotically assisted hysterectomy for benign gynecologic disease
I’m getting a lot of emails about this study: BACKGROUND: Observational cohort studies and a secondary prevention trial have shown an inverse association between adherence to
So I finally got around to reading Steven Brill’s piece in Time this weekend. Yeah it took me a while, but man – why so
There’s already been a lot of reaction to Steven Brill’s way-too-long Time cover story on the variation of health care prices across payers and what
I have little doubt Watson could be usefully applied in the field of medicine, which is not to say it will reduce spending. One thing
The results of SYNTAX are clear. Overall, at 5 years CABG [coronary artery bybass grafting] significantly reduced major adverse cardiac and cerebrovascular events (MACCE) at
Via Explore and h/t Paul Kelleher. @afrakt
I recently interviewed Ilene Flannery Wells, who discussed her struggles to care for her now-deceased schizophrenic twin brother Paul Flannery. Flannery spent much of his life
I had a bit of a Twitter flurry this morning, with some back-and-forth with Avik Roy. One of the things that came up in the
The do-it-yourself test market, estimated at $2 billion to $3 billion globally, is expanding 20 percent a year as new checks for colon and prostate